Vivian Tian

To learn about Ms. Tian's practice, please visit https://www.rothwellfigg.com/professionals/tianv.

Follow:

mRNA Patent and Competitive Landscape: 2021 Year in Review and 2022 Outlook

By Dan Shores, Vivian Tian & Sheena Wang on January 3, 2022

Posted in Featured, Trends & Analysis

In April of 2021, we provided a three-part series relating to the IP and Competitive Landscape for the mRNA market.
Continue Reading mRNA Patent and Competitive Landscape: 2021 Year in Review and 2022 Outlook

Moderna’s Next Steps: Spikevax Today, Gene Editing Tomorrow

By Vivian Tian on August 16, 2021

Posted in Featured, Trends & Analysis

Following the successful development (and financial success) of its mRNA vaccine, biotech company Moderna is now looking to expand into…
Continue Reading Moderna’s Next Steps: Spikevax Today, Gene Editing Tomorrow

We use cookies to enhance your user experience. By continuing to use this site you are giving your consent for us to use cookies. For more information, please see our Privacy Policy.